$LMAT News

LeMaitre Vascular: 31% Drawdown On $0.02 Guidance Cut

Wells Fargo Maintains Equal-Weight on LeMaitre Vascular, Lowers Price Target to $94

LeMaitre Vascular (NASDAQ:LMAT) Shares Slide on Q2 Earnings Miss

LeMaitre Vascular, Inc. (LMAT) Q2 2026 Earnings Call Transcript

LeMaitre Vascular Sees Q4 GAAP EPS $0.75-$0.81 vs $0.78 Est; Sees Sales $71.100M-$73.100M vs $72.745M Est

LeMaitre Vascular Sees Q3 GAAP EPS $0.66-$0.71 vs $0.73 Est; Sees Sales $66.300M-$68.300M vs $69.246M Est

LeMaitre Vascular Lowers FY2026 GAAP EPS Guidance from $2.93-$3.08 to $2.84-$2.94 vs $2.97 Est; Lowers FY2026 Sales Guidance from $277.000M-$283.000M to $274.300M-$278.300M vs $279.948M Est

LeMaitre Vascular Q2 EPS $0.74 Misses $0.79 Estimate, Sales $70.382M Miss $70.973M Estimate

LeMaitre Vascular Inc. (NASDAQ:LMAT) Passes the Quality Test with Caviar Cruise Screen

How The LeMaitre Vascular (LMAT) Story Is Shifting As Analysts Lift Fair Value Targets

LeMaitre (LMAT) is an Incredible Growth Stock: 3 Reasons Why

1 Reason to Avoid LMAT and 1 Stock to Buy Instead

Winners And Losers Of Q1: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks

LeMaitre to Participate at Upcoming Investor Conferences in June

5 Insightful Analyst Questions From LeMaitre’s Q1 Earnings Call

Down 17.2% in 4 Weeks, Here's Why LeMaitre (LMAT) Looks Ripe for a Turnaround

LeMaitre Vascular Inc (NASDAQ:LMAT): A Quality Investing Candidate Passing All Caviar Cruise Screen Tests

Insider Transaction: George LeMaitre Sells $5.03M Worth Of LeMaitre Vascular Shares

US$118 - That's What Analysts Think LeMaitre Vascular, Inc. (NASDAQ:LMAT) Is Worth After These Results

3 Reasons Growth Investors Will Love LeMaitre (LMAT)